Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) accelerates osteoclast formation by regulating signal transducer and activator of transcription 3 (STAT3) signalling

MYC-mediated miR-320a affects receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast formation by regulating phosphatase and tensin homolog (PTEN)

(2021) Hao Chen et al.   Bioengineered

METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export

(2020) Di Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Associations of Serum Cathepsin K and Polymorphisms in CTSK Gene With Bone Mineral Density and Bone Metabolism Markers in Postmenopausal Chinese Women

(2020) Li-hong Gao et al.   Frontiers in Endocrinology

Lipopolysaccharide Promotes Inflammatory Response via Enhancing IFIT1 Expression in Human Umbilical Vein Endothelial Cells

(2020) Jia-Li Wang et al.   DNA AND CELL BIOLOGY

Cathepsin K: The Action in and Beyond Bone

(2020) Rongchen Dai et al.   Frontiers in Cell and Developmental Biology

STAT3 and its targeting inhibitors in osteosarcoma

(2020) Yun Liu et al.   CELL PROLIFERATION

Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo

(2020) Yu-Xi Li et al.   Stem Cells International

IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling

(2019) Vijaya Kumar Pidugu et al.   ONCOGENE

Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway

(2019) Guangxia Yang et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Developmental origin, functional maintenance and genetic rescue of osteoclasts

(2019) Christian E. Jacome-Galarza et al.   NATURE

Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor

(2019) Emma Persson et al.   Frontiers in Immunology

Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo

(2019) Xuzhuo Chen et al.   EXPERIMENTAL CELL RESEARCH

STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription

(2019) Yiling Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma

(2019) Hao Li et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Glucose uptake inhibition decreases expressions of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteocalcin in osteocytic MLO-Y4-A2 cells

(2018) Ayumu Takeno et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Nicorandil and theophylline can protect experimental rats against complete Freund's adjuvant-induced rheumatoid arthritis through modulation of JAK/STAT/RANKL signaling pathway

(2018) Ahmed Gaafar Ahmed Gaafar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Regulation of Osteoclast Differentiation by Cytokine Networks

(2018) Dulshara Sachini Amarasekara et al.   Immune Network

Nutrient stress-dysregulated antisense lncRNA GLS-AS impairs GLS-mediated metabolism and represses pancreatic cancer progression

(2018) Shi-jiang Deng et al.   CANCER RESEARCH

Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned

(2017) Matthew T Drake et al.   ENDOCRINE REVIEWS

Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis

(2016) Augustin Latourte et al.   ANNALS OF THE RHEUMATIC DISEASES

STAT3 signaling in immunity

(2016) Emily J. Hillmer et al.   CYTOKINE & GROWTH FACTOR REVIEWS

DC-STAMP: A Key Regulator in Osteoclast Differentiation

(2016) Ya-Hui Chiu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Peroxiredoxin II Negatively Regulates Lipopolysaccharide-Induced Osteoclast Formation and Bone Loss via JNK and STAT3

(2015) Hyojung Park et al.   ANTIOXIDANTS & REDOX SIGNALING

DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates

(2015) Jieun Shin et al.   Science Translational Medicine

IFIT1: A dual sensor and effector molecule that detects non-2′-O methylated viral RNA and inhibits its translation

(2014) Michael S. Diamond   CYTOKINE & GROWTH FACTOR REVIEWS

Interferon-Induced Ifit Proteins: Their Role in Viral Pathogenesis

(2014) Volker Fensterl et al.   JOURNAL OF VIROLOGY

Interferon Induced IFIT Family Genes in Host Antiviral Defense

(2013) Xiang Zhou et al.   International Journal of Biological Sciences

Therapeutic targeting of osteoclast function and pathways

(2011) Matthew L Broadhead et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

ATP6v0d2 deficiency increases bone mass, but does not influence ovariectomy-induced bone loss

(2010) Taesoo Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Complex Regulation of Tartrate-resistant Acid Phosphatase (TRAP) Expression by Interleukin 4 (IL-4)

(2009) Minjun Yu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of action

(2009) Mohammad Amin Kerachian et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy

(2008) Alison R. Hayman   AUTOIMMUNITY